GILD Stock Soars on HIV Drug Data: Gilead’s shares gained after the company announced upbeat results from an interim analysis of a second late-stage study evaluating the use of the company’s ...

2 [Alt text] From left to right, the figure outlines key elements of posttranscriptional pre-mRNA splicing: an RNA transcript (pre-mRNA) displaying introns and exons, and six common splicing ...

Genetic evidence from a new report suggests the coronavirus pandemic most likely spilled over from animals in the Wuhan ...

Neurological conditions can result from chronic hyponatremia, a disorder marked by low blood salt levels. In addition, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

New York, New York-- (Newsfile Corp. - September 18, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18 ...

Low serum sodium concentrations in the blood are called hyponatremia, a prevalent clinical electrolyte disorder. In contrast ...

How is VOO stock faring? The Vanguard S&P 500 ETF has been almost flat over the past five days but has risen about 19% over ...

Shares of Moderna Inc. MRNA shed 2.96% to $69.86 Wednesday, on what proved to be an all-around dismal trading session for the ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...

Find out more about six immunology companies that have recently raised impressive funds in the biotech industry.